Address

Prospect Venture Partners
435 Tasso Street
Suite 200
Palo Alto, CA 94301
United States

Open map


Recent investment activity

KANDO id: 28604

Corporate information

Registration country

Company type

Venture capital firm

Funding rounds

Top investment portfolio themes

Actual initial investment stage
N/A (1)
Venture (1)

Investment activity status
Active investor

Selected investments

Displaying 26 - 48 of 48
Profile Country Date Funding
Tercica Inc A biopharmaceutical company developing new therapeutics for endocrine system disorders. N/A
TOPICA Pharmaceuticals Inc A privately held clinical research stage pharmaceutical company Series B
Transave Inc N/A
Trubion Pharmaceuticals Inc N/A
Vanda Pharmaceuticals Inc Biopharmaceutical company focused on the development and commercialization of clinical-stage products for central nervous system disorders. N/A
Vitae Pharmaceuticals Inc Drug discovery company developing optimized drugs using proprietary computational drug design platform. N/A
Allux Medical Inc Medical device company developing medical devices for the treatment of hyper-reactive airway mucosa. N/A Initial investment
Alvine Pharmaceuticals Inc An innovative biopharmaceutical company developing biologics to target autoimmune/ inflammatory diseases. N/A
AVEO Pharmaceuticals Inc Biopharmaceutical company discovering, developing and commercializing cancer therapeutics. N/A
Baxano Inc A medical device company focused on developing minimally invasive tools to restore spine function and preserve healthy tissue. Series C
Complete Genomics Inc Series E
Complete Genomics Inc Series D
Hansen Medical Inc Hansen Medical makes an electromechanical robotic system. Series C
KYTHERA Biopharmaceuticals Inc Series B
Nanosys Inc Nanotechnology-enabled systems N/A
Neomend Inc A biomedical device company, engages in the development and commercialization of surgical wound healing products Series D
Portola Pharmaceuticals Inc N/A
Rinat Neuroscience Corp Discovers and commercializes novel antibody based drugs and drug targets for the major mental and neuro-degenerative diseases Series B Initial investment
Senomyx Inc Discovery and development of innovative flavor ingredients for the food, beverage, and ingredient supply industries N/A
SentreHEART Inc A medical device company that has developed catheter-based solutions to address unmet clinical needs. Series C Initial investment
TherOx Inc N/A
Visiogen Inc A medical device company focused on dual-optic accommodating intraocular lens, called Synchrony, for the treatment of age-related vision loss. Series D Initial investment
Visiogen Inc A medical device company focused on dual-optic accommodating intraocular lens, called Synchrony, for the treatment of age-related vision loss. Venture Initial investment

Current team

Past employees

Selected Products / Customers

Financials